Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410124 | SCV000487103 | likely pathogenic | Bifunctional peroxisomal enzyme deficiency | 2016-10-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000802983 | SCV000942835 | pathogenic | Bifunctional peroxisomal enzyme deficiency; Perrault syndrome | 2021-03-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu545Cysfs*8) in the HSD17B4 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in HSD17B4 are known to be pathogenic (PMID: 11810648, 16385454). This variant has not been reported in the literature in individuals with HSD17B4-related conditions. ClinVar contains an entry for this variant (Variation ID: 371505). This variant is not present in population databases (ExAC no frequency). |
Baylor Genetics | RCV000410124 | SCV004192426 | likely pathogenic | Bifunctional peroxisomal enzyme deficiency | 2022-09-16 | criteria provided, single submitter | clinical testing |